Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium bicarbonate cotransporter 3 (SLC4A7, also known as NBCn1) is a member of the solute carrier family 4, functioning as an electroneutral sodium and bicarbonate cotransporter found in the plasma membrane of many cell types including those in the nervous, cardiovascular, and gastrointestinal systems[2][4][5][6]. By coupling the movement of Na⁺ and HCO₃⁻ ions, SLC4A7 plays a crucial role in regulating intracellular pH, acid–base homeostasis, and transepithelial movement of electrolytes. The transporter exists in numerous splice variants and participates in net acid extrusion, cellular volume regulation, and modulation of cell survival. Dysfunction has been linked to cardiovascular pathologies, certain cancers, and potentially neurological diseases[2][5][6]. While targeted inhibitors are under research for cancer therapy, no approved drugs currently act directly on SLC4A7, making it a promising but as-yet underexploited therapeutic target[2].
Inhibitors block sodium and bicarbonate ion cotransport for modulation of pH and cell viability, particularly in cancer therapeutics research[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium bicarbonate cotransporter 3 (SLC4A7).